Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VR506 (Fluticasone Propionate) in Asthma
NCT01472757Phase 3Completed
- Sponsor
- Vectura
- Start
- Oct 2011
- Primary completion
- May 2013
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
Phase 3, randomised, double-blind trial of fluticasone propionate nasal spray in asthma (4 arms), sponsored by Vectura. Primary endpoint: Forced Expiratory Volume in 1 Second at 12 weeks. Started Oct 2011; status: completed.
02
Drugs
fluticasone propionate nasal spray
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01472757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01472757.